SCHEMBL182567

SCHEMBL182567

CCCCN(CCCC)C(=O)N(CCCC)CCCC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 5/20 0.61
CA12 O43570 5/20 0.61
CA9 Q16790 5/20 0.61
MMP1 P03956 1/20 0.56
MMP2 P08253 1/20 0.56
MMP3 P08254 1/20 0.56
MMP8 P22894 1/20 0.56
ALDH1A1 P00352 3/20 0.48
ALDH2 P05091 1/20 0.48
CES1 P23141 3/20 0.48
CES2 O00748 2/20 0.48
CA2 P00918 3/20 0.44
TP53 P04637 1/20 0.43
GAA P10253 1/20 0.40
HPGD P15428 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrogen Sulfide SCHEMBL28326725 0.97 CA1 (0.58) CA1CA12CA9MMP1MMP2
SCHEMBL8856903 0.92 CA12 (0.61) CA1CA12CA9MMP1MMP2
SCHEMBL20625244 0.92 CA12 (0.54) CA1CA12CA9MMP1MMP2
SCHEMBL5827268 0.92 CA12 (0.52) CA1CA12CA9MMP1MMP2
SCHEMBL10388723 0.90 CA1 (0.52) CA1CA12CA9MMP1MMP2
SCHEMBL25278271 0.89 CA12 (0.54) CA1CA12CA9MMP1MMP2
SCHEMBL25227890 0.89 CA12 (0.54) CA1CA12CA9MMP1MMP2
SCHEMBL25220731 0.89 CA12 (0.54) CA1CA12CA9MMP1MMP2
SCHEMBL11013278 0.89 CA12 (0.54) CA1CA12CA9MMP1MMP2
SCHEMBL25277341 0.89 CA12 (0.54) CA1CA12CA9MMP1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1758 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122059817-A Preparation method of 2-alkyl tetrahydroanthraquinone and application of 2-alkyl tetrahydroanthraquinone in hydrogen peroxide process 黎明化工研究设计院有限责任公司 2026-05-19 CN claimed
US-12509598-B2 Process solution composition for polymer treatment comprising a fluorine compound, a ketone solvent, and a polar aprotic solvent DONGWOO FINE-CHEM CO., LTD. (KR) 2025-12-30 US claimed
US-20250321481-A1 PHOTOSENSITIVE RESIN COMPOSITION TOKYO OHKA KOGYO CO LTD (JP) 2025-10-16 US claimed
US-20250297039-A1 OLEFIN POLYMERIZATION CATALYST COMPONENTS CONTAINING DIGLYCIDYLESTER COMPONENTS AND ITS USE FOR THE PRODUCTION OF POLYPROPYLENE HAVING HIGH ISOTACTICITY AT HIGH MELT FLOW RATE FORMOSA PLASTICS CORP USA (US) 2025-09-25 US claimed
CN-222956213-U Solid phosgene dissolving tank device for tetrabutyl urea 山东门捷新材料股份有限公司 2025-06-10 CN claimed
CN-120079322-A Limited domain fluidization continuous reactor for anthraquinone hydrogenation 衢州资源化工创新研究院 2025-06-03 CN claimed
CN-120025542-A Non-isocyanate polyurethane and multicomponent selective synthesis method thereof 华南理工大学 2025-05-23 CN claimed
US-20250115686-A1 OLEFIN POLYMERIZATION CATALYST COMPONENTS CONTAINING SILANE AND PROCESS FOR THE PRODUCTION OF POLYPROPYLENE HAVING HIGH ISOTACTICITY AT HIGH MELT FLOW RATE FORMOSA PLASTICS CORP USA (US) 2025-04-10 US claimed
CN-119660679-A Method for producing high-concentration hydrogen peroxide by extraction 杭州澜通科技有限公司 2025-03-21 CN claimed
CN-119660680-A Method for preparing high-concentration hydrogen peroxide 杭州澜通科技有限公司 2025-03-21 CN claimed
EP-0053981-B1 PROCESS FOR PREPARING THIOCHLOROFORMIATES SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) 1985-04-10 EP claimed
EP-0080913-B1 PROCESS FOR THE SYNTHESIS OF CHLOROFORMIC ACID CHLOROMETHYL ESTER SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) 1985-03-13 EP claimed
EP-0063067-B1 PROCESS FOR THE MANUFACTURE OF SILANE RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1983-11-23 EP claimed
EP-0093640-A1 Process for the manufacture of silane from trichlorosilane RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1983-11-09 EP claimed
US-4405590-A Dismutation/redistribution of halogenosilanes into silane RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1983-09-20 US claimed
US-4400329-A Process for the manufacture of thiochlorformates SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) 1983-08-23 US claimed
EP-0080913-A1 Process for the synthesis of chloroformic acid chloromethyl ester SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) 1983-06-08 EP claimed
EP-0037016-B1 PROCESS FOR EXTRACTING AND PRODUCING THIOGLYCOLIC ACID FROM AQUEOUS SOLUTIONS CASSELLA Aktiengesellschaft (DE) 1983-04-06 EP claimed
EP-0063067-A1 Process for the manufacture of silane RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1982-10-20 EP claimed
EP-0053981-A1 Process for preparing thiochloroformiates SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) 1982-06-16 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12509598-B2 Process solution composition for polymer treatment comprising a fluorine compound, a ketone solvent, and a polar aprotic solvent CHRM1, CHRM2, PNMT CA1 803/4885CA12 2138/4885CA9 2920/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.